Tradestie Institutional Equity Comparison Engine
STTK vs EQ โ Head-to-Head Terminal
6-dimension institutional benchmarking across valuation, multi-year operating margins, normalized momentum, and dealer gamma corridors.
Pillar 1 Executive Scorecard & Category Winner Tally
EQ Overall Edge
EQ Captures Institutional Edge (2โ1 Pillars ยท 3โ5 Matrix Metrics)
Tradestie Institutional Equity Comparison Engine assigns the overall head-to-head edge to Equillium, Inc. Common Stock (EQ) driven by superior Valuation, Options & Structure while STTK counters with relative strength in Momentum & Technical. Fundamentally, STTK trades at N/M Forward P/E with 0.0% operating margin (-66.6% YoY revenue) versus EQ at 1.5x Forward P/E and 0.0% operating margin (-52.3% YoY). In options structure, STTK sits in BREAKDOWN (10th %ile IV; Dealer Gamma Walls on Pro) against EQ sits in UNCLASSIFIED (100th %ile IV; Dealer Gamma Walls on Pro).
Valuation Winner
EQ
STTK N/M vs EQ 1.5x Fwd P/E
Growth & Margin Winner
Tie
Op Margin 0.0% vs 0.0% ยท YoY -66.6% vs -52.3%
Momentum & Technical Winner
STTK
1Y +126.4% vs +12.0% ยท 52W Pos 41% vs 11%
Options & Structure Winner
EQ
BREAKDOWN (10th %ile IV) vs UNCLASSIFIED (100th %ile IV)
STTK
NASDAQ
Shattuck Labs, Inc. Common Stock
Pharmaceutical Preparations
$4.55
+1.79% 1D
Market Cap
$459.8M
1M Return
-18.46%
1Y Return
+126.37%
Forward P/E
N/M
Unified AI Score
58.4 / 100
HOLD
Tech 82.0
Fund 50.0
Flow 63.0
Mom 60.0
EQ
NASDAQ
Equillium, Inc. Common Stock
Pharmaceutical Preparations
$1.12
+1.82% 1D
Market Cap
$90.6M
1M Return
-21.13%
1Y Return
+12.0%
Forward P/E
1.5x
Unified AI Score
48.0 / 100
HOLD
Tech 30.0
Fund 51.0
Flow 63.0
Mom 60.0
Pillar 2 Normalized Relative Return Performance (% Indexed to 0%)
1Y Indexed Return:
STTK +126.37%
EQ +12.0%
Spread: +114.37 pp (STTK Lead)
Pillar 3 Multi-Year Annual Revenue & Operating Margin Trajectory (USD)
| Period | STTK Revenue | EQ Revenue | STTK Op. Margin | EQ Op. Margin | Margin Edge |
|---|---|---|---|---|---|
| FY2019 | $10M | N/A | -253.5% | N/A | STTK |
| FY2020 | $10M | N/A | -371.8% | N/A | STTK |
| FY2021 | $30M | N/A | -150.8% | N/A | STTK |
| FY2022 | $0M | $20M | -15848.0% | -393.9% | EQ |
| FY2023 | $0M | $40M | -5549.6% | -40.2% | EQ |
| FY2024 | $10M | $40M | -1408.3% | -20.1% | EQ |
| FY2025 | $0M | N/A | -5150.8% | N/A | STTK |
Pillar 4 Head-to-Head Fundamental & Valuation Matrix
| Institutional Metric | STTK | EQ | Criterion | Row Winner |
|---|---|---|---|---|
| Market Capitalization Scale | $459.8M | $90.6M | Larger Scale | STTK |
| Trailing P/E Ratio Valuation | N/M | 1.5x | Lower Multiple | EQ |
| Forward P/E Ratio Valuation | N/M | 1.5x | Lower Multiple | EQ |
| Revenue Growth (YoY) Growth | -66.6% | -52.3% | Higher Growth | EQ |
| Operating Margin (TTM) Profitability | 0.0% | 0.0% | Higher Margin | Tie |
| Net Profit Margin Profitability | 0.0% | 0.0% | Higher Margin | Tie |
| Return on Equity (ROE) Capital Efficiency | -47.2% | -59.0% | Higher ROE | STTK |
| 52-Week Range Position Momentum | 41% ($2โ$8) | 11% ($1โ$4) | Stronger Trend | STTK |
| Beta / 30D Volatility Risk Regime | 1.46ฮฒ ยท 68% Vol | 1.53ฮฒ ยท 93% Vol | Lower Realized Risk | STTK |
| Unified Institutional Score Composite Signal | 58.4 / 100 (HOLD) | 48.0 / 100 (HOLD) | Higher Composite | STTK |
Pillar 5 Options Structure, IV Regime & Dealer Gamma Corridor
Full STTK vs EQ Buy Guide
STTK
BREAKDOWN
61d in phase ยท OBV NEUTRAL
Put Wall Floor
Pro Only
Call Wall Magnet
Pro Only
IV Percentile
10th %ile
IV Regime
Compressed (<25th %ile)
EQ
UNCLASSIFIED
0d in phase ยท OBV NEUTRAL
Put Wall Floor
Pro Only
Call Wall Magnet
Pro Only
IV Percentile
100th %ile
IV Regime
Extreme (>80th %ile)
Pillar 6 90-Day Technical & R&D Innovation Disclosures
Corporate R&D & Foundry Tracker
Neither STTK nor EQ registered frontier semiconductor/AI engineering publications in the trailing 90-day window; head-to-head edge is anchored on operating margin trajectory, valuation multiples, and options structure above.